Hedge Fund - Sectoral Asset Management
Vertex Pharmaceuticals Inc / Ma (VRTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $2,290,775 | 1.78% | 4,725 | $466.00 |
| 2 | 2024 - Q4 (2024-12-31) | $1,477,909 | 0.98% | 3,670 | $463.53 |
| 3 | 2024 - Q3 (2024-09-30) | $2,250,987 | 1.32% | 4,840 | $480.37 |
| 4 | 2024 - Q2 (2024-06-30) | $4,054,428 | 1.64% | 8,650 | $434.05 |
| 5 | 2024 - Q1 (2024-03-31) | $3,013,852 | 1.18% | 7,210 | $422.74 |
| 6 | 2023 - Q4 (2023-12-31) | $3,751,119 | 1.61% | 9,219 | $369.42 |
| 7 | 2023 - Q3 (2023-09-30) | $3,049,332 | 0.59% | 8,769 | $349.73 |
| 8 | 2023 - Q2 (2023-06-30) | $2,872,993 | 0.47% | 8,164 | $336.94 |
| 9 | 2023 - Q1 (2023-03-31) | $2,085,448 | 0.4% | 6,619 | $299.93 |
| 10 | 2022 - Q4 (2022-12-31) | $2,026,947 | 0.39% | 7,019 | $304.77 |
| 11 | 2022 - Q3 (2022-09-30) | $2,293,000 | 0.45% | 7,918 | $287.72 |
| 12 | 2022 - Q2 (2022-06-30) | $2,288,000 | 0.46% | 8,118 | $267.66 |
| 13 | 2022 - Q1 (2022-03-31) | $1,900,000 | 0.33% | 7,281 | $237.33 |
| 14 | 2021 - Q4 (2021-12-31) | $1,707,000 | 0.25% | 7,771 | $194.45 |
| 15 | 2021 - Q3 (2021-09-30) | $1,763,000 | 0.14% | 9,721 | $195.24 |
| 16 | 2021 - Q2 (2021-06-30) | $1,960,000 | 0.15% | 9,721 | $209.17 |
| 17 | 2021 - Q1 (2021-03-31) | $2,433,000 | 0.18% | 11,321 | $219.65 |
| 18 | 2020 - Q4 (2020-12-31) | $3,999,000 | 0.28% | 16,921 | $229.44 |
| 19 | 2020 - Q3 (2020-09-30) | $2,686,000 | 0.23% | 9,871 | $275.88 |
| 20 | 2020 - Q2 (2020-06-30) | $4,259,000 | 0.39% | 14,671 | $271.12 |
| 21 | 2020 - Q1 (2020-03-31) | $3,848,000 | 0.73% | 16,171 | $229.39 |
| 22 | 2019 - Q4 (2019-12-31) | $3,519,000 | 0.52% | 16,071 | $202.38 |
| 23 | 2019 - Q3 (2019-09-30) | $2,401,000 | 0.41% | 14,171 | $176.91 |
| 24 | 2019 - Q2 (2019-06-30) | $6,926,000 | 0.82% | 37,771 | $174.82 |
| 25 | 2019 - Q1 (2019-03-31) | $3,729,000 | 0.44% | 20,271 | $184.70 |
| 26 | 2018 - Q4 (2018-12-31) | $6,002,000 | 0.81% | 36,217 | $173.27 |
| 27 | 2018 - Q3 (2018-09-30) | $14,811,000 | 1.57% | 76,846 | $178.07 |
| 28 | 2018 - Q2 (2018-06-30) | $0 | 0% | 0 | $155.01 |
| 29 | 2018 - Q1 (2018-03-31) | $6,831,000 | 0.74% | 41,915 | $163.34 |
| 30 | 2017 - Q4 (2017-12-31) | $5,502,000 | 0.68% | 36,715 | $148.07 |
| 31 | 2017 - Q3 (2017-09-30) | $5,169,000 | 0.66% | 34,000 | $150.51 |
| 32 | 2016 - Q4 (2016-12-31) | $0 | 0% | 0 | $81.37 |
| 33 | 2016 - Q3 (2016-09-30) | $19,001,000 | 1.86% | 217,874 | $94.50 |
| 34 | 2016 - Q2 (2016-06-30) | $19,920,000 | 2.05% | 231,575 | $86.41 |
| 35 | 2016 - Q1 (2016-03-31) | $71,261,000 | 3.44% | 896,479 | $90.45 |
| 36 | 2015 - Q4 (2015-12-31) | $86,596,000 | 3.69% | 688,200 | $120.72 |
| 37 | 2015 - Q3 (2015-09-30) | $76,460,000 | 3.5% | 734,200 | $128.47 |
| 38 | 2015 - Q2 (2015-06-30) | $73,940,000 | 3.08% | 598,800 | $125.98 |
| 39 | 2015 - Q1 (2015-03-31) | $60,118,000 | 2.28% | 509,600 | $119.81 |
| 40 | 2014 - Q4 (2014-12-31) | $25,215,000 | 1.13% | 212,250 | $112.63 |
| 41 | 2014 - Q3 (2014-09-30) | $37,051,000 | 1.55% | 329,897 | $95.21 |
| 42 | 2014 - Q2 (2014-06-30) | $102,204,000 | 4.33% | 1,079,464 | $70.12 |
| 43 | 2014 - Q1 (2014-03-31) | $90,291,000 | 3.71% | 1,276,741 | $79.20 |
| 44 | 2013 - Q4 (2013-12-31) | $91,549,000 | 3.94% | 1,232,158 | $69.64 |
| 45 | 2013 - Q3 (2013-09-30) | $93,695,000 | 4.5% | 1,235,755 | $79.57 |
| 46 | 2013 - Q2 (2013-06-30) | $202,233,000 | 5.98% | 2,526,014 | $73.64 |
| 47 | 2013 - Q1 (2013-03-31) | $192,022,000 | 5.9% | 3,493,219 | $48.01 |
| 48 | 2012 - Q4 (2012-12-31) | $142,341,000 | 4.97% | 3,397,168 | $46.18 |
| 49 | 2012 - Q3 (2012-09-30) | $204,843,000 | 6.68% | 3,665,110 | $53.75 |
The displayed share prices are average quarterly stock market prices.